Mark V Sherrid (Mark Sherrid)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Venues

Journal of the American Heart Association

Circulation. Cardiovascular imaging

Echocardiography (Mount Kisco, N.Y.)

Circulation. Cardiovascular interventions

NYU School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

NYU School of Medicine May 07 2015

United States

Member of the Faculty :: Medicine. Cardiology

Publications

Milind Y Desai, Yuichiro Okushi, Andrew Gaballa, Qiuqing Wang, Jeffrey B Geske, Anjali Tiku Owens, Sara Saberi, Andrew Wang, Paul C Cremer, Mark V Sherrid, Neal K Lakdawala, Albree Tower-Rader, David Fermin, Srihari S Naidu, Kathy L Lampl, Amy J Sehnert, Steven E Nissen, Zoran B Popovic, null null
Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial. Circulation. Cardiovascular imaging (2024)
Rodolfo Citro, Michele Bellino, Elisa Merli, Davide Di Vece, Mark V Sherrid
Obstructive Hypertrophic Cardiomyopathy and Takotsubo Syndrome: How to Deal With Left Ventricular Ballooning? Journal of the American Heart Association (2023)
Daniele Massera, Mark V Sherrid
What Predicts the Success of Alcohol Septal Ablation?: The Myocardium Counts, After All. Circulation. Cardiovascular interventions 16 (8) (2023)
Barry J Maron, Martin S Maron, Mark V Sherrid, Ethan J Rowin
Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy. Journal of the American Heart Association 11 (9) (2022)
Milind Y Desai, Anjali Tiku Owens, Jeffrey B Geske, Kathy Wolski, Sara Saberi, Andrew Wang, Mark V Sherrid, Paul C Cremer, Srihari S Naidu, Nicholas G Smedira, Hartzell V Schaff, Ellen McErlean, Christina Sewell, Aarthi Balasubramanyam, Kathy Lampl, Amy J Sehnert, Steven E Nissen
Dose-Blinded Myosin Inhibition in Patients with Obstructive HCM Referred for Septal Reduction Therapy: Outcomes Through 32-Weeks. Circulation (2022)
Paul C Cremer, Jeffrey B Geske, Anjali Tiku Owens, Wael A Jaber, Serge C Harb, Sara Saberi, Andrew Wang, Mark V Sherrid, Srihari S Naidu, Hartzell Schaff, Nicholas G Smedira, Qiuqing Wang, Kathy Wolski, Kathy L Lampl, Amy J Sehnert, Steven E Nissen, Milind Y Desai
Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM Study. Circulation. Cardiovascular imaging (2022)
Mark V Sherrid, Daniel G Swistel, Iacopo Olivotto, Maurizio Pieroni, Omar Wever-Pinzon, Katherine Riedy, Richard G Bach, Mustafa Husaini, Sharon Cresci, Alex Reyentovich, Daniele Massera, Martin S Maron, Barry J Maron, Bette Kim
Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy. Journal of the American Heart Association 10 (20) (2021)
Milla E Arabadjian, Gary Yu, Mark V Sherrid, Victoria Vaughan Dickson
Disease Expression and Outcomes in Black and White Adults With Hypertrophic Cardiomyopathy. Journal of the American Heart Association 10 (17) (2021)
Mark V Sherrid, Katherine Riedy, Barry Rosenzweig, Monica Ahluwalia, Milla Arabadjian, Muhamed Saric, Sandhya Balaram, Daniel G Swistel, Harmony R Reynolds, Bette Kim
Hypertrophic cardiomyopathy with dynamic obstruction and high left ventricular outflow gradients associated with paradoxical apical ballooning. Echocardiography (Mount Kisco, N.Y.) 36 (1) (2018)
Mark V Sherrid, Josef Kushner, Georgiana Yang, Richard Ro
Mitral valve coaptation and its relationship to late diastolic flow: A color Doppler and vector flow map echocardiographic study in normal subjects. Echocardiography (Mount Kisco, N.Y.) 34 (4) (2017)

Mark V Sherrid (Mark Sherrid)

Publication Activity (10 Years)

Top Topics

Top Venues